Patents by Inventor Joseph S. Raven
Joseph S. Raven has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9795498Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: GrantFiled: October 3, 2013Date of Patent: October 24, 2017Assignee: APOLLO ENDOSURGERY US, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Publication number: 20160331568Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: ApplicationFiled: October 3, 2013Publication date: November 17, 2016Applicant: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Publication number: 20150272761Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: ApplicationFiled: October 3, 2013Publication date: October 1, 2015Applicant: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Patent number: 9138308Abstract: The present specification discloses porous materials, methods of forming such porous material, biocompatible implantable devices comprising such porous materials, and methods of making such biocompatible implantable devices. The porous material may be used to fix to the interior mucosal lining of a patient's gastrointestinal tract.Type: GrantFiled: August 2, 2012Date of Patent: September 22, 2015Assignee: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Joseph S. Raven, Futian Liu
-
Publication number: 20150133877Abstract: An implantable injection port facilitates filling and/or draining an inflatable portion of a gastric band. In an embodiment, the port comprises a movable cap that causes anchor wires to extend from anchor devices in order to implant the injection port in the tissue of a patient. In another embodiment, the port comprises a handle that rotates to implant curved anchors into the tissue of a patient. In yet another embodiment, a cap is configured to move towards a base of the port in order to cause the curved anchors to rotate into the tissue of a patient. The cap may also rotate with respect to the base in order to lock the cap and the anchors in position. Further, surfaces of the injection port may be textured to increase adhesiveness to the patient's tissue during installation and to facilitate simpler installation.Type: ApplicationFiled: November 11, 2014Publication date: May 14, 2015Applicant: Apollo Endosurgery, Inc.Inventors: James A. Harders, Joseph S. Raven, Dimitrios Stroumpoulis, Nikhil S. Trilokekar
-
Publication number: 20140358062Abstract: An intraluminal sleeve system is provided, which generally includes an intraluminal sleeve capable of dispensing an active agent to a patient, for example, a metabolic agent or satiety inducing agent. The intraluminal sleeve may be structured to contain the active agent and permit controlled release of the active agent to the patient while the intraluminal sleeve is positioned within the patient's intestine. Methods for treating obesity are also provided which include positioning an intraluminal sleeve in a patient's intestine, the intraluminal sleeve being capable of dispensing an active agent to the patient. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.Type: ApplicationFiled: July 29, 2014Publication date: December 4, 2014Applicant: Apollo Endosurgery, Inc.Inventors: Joseph S. Raven, Janel A. Birk
-
Patent number: 8888732Abstract: An intraluminal sleeve system is provided, which generally includes an intraluminal sleeve capable of dispensing an active agent to a patient, for example, a metabolic agent or satiety inducing agent. The intraluminal sleeve may be structured to contain the active agent and permit controlled release of the active agent to the patient while the intraluminal sleeve is positioned within the patient's intestine. Methods for treating obesity are also provided which include positioning an intraluminal sleeve in a patient's intestine, the intraluminal sleeve being capable of dispensing an active agent to the patient. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.Type: GrantFiled: March 11, 2011Date of Patent: November 18, 2014Assignee: Apollo Endosurgery, Inc.Inventors: Joseph S. Raven, Janel A. Birk
-
Patent number: 8882728Abstract: An implantable injection port facilitates filling and/or draining an inflatable portion of a gastric band. In an embodiment, the port comprises a movable cap that causes anchor wires to extend from anchor devices in order to implant the injection port in the tissue of a patient. In another embodiment, the port comprises a handle that rotates to implant curved anchors into the tissue of a patient. In yet another embodiment, a cap is configured to move towards a base of the port in order to cause the curved anchors to rotate into the tissue of a patient. The cap may also rotate with respect to the base in order to lock the cap and the anchors in position. Further, surfaces of the injection port may be textured to increase adhesiveness to the patient's tissue during installation and to facilitate simpler installation.Type: GrantFiled: February 10, 2010Date of Patent: November 11, 2014Assignee: Apollo Endosurgery, Inc.Inventors: James A. Harders, Joseph S. Raven, Dimitrios Stroumpoulis, Nikhil S. Trilokekar
-
Publication number: 20140288535Abstract: An implantable intragastric volume occupying device system is provided which generally includes a volume occupying device and an active agent, for example, a metabolic agent or satiety inducing agent. The volume occupying device may be structured to contain the agent and permit controlled release of the agent to the patient while the volume occupying device is positioned within the patient's stomach. Methods for treating obesity are also provided which include positioning a volume occupying device in the stomach of a patient and administering a satiety inducing agent to the patient while the volume occupying device is positioned in the stomach. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.Type: ApplicationFiled: June 3, 2014Publication date: September 25, 2014Applicant: Apollo Endosurgery, Inc.Inventors: Joseph S. Raven, Janel A. Birk
-
Patent number: 8715158Abstract: The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port with a bottom exit port and method for attaching an access port to a patient. In addition, a tube guard, flexible tube exit port, tissue guard, and porous coupling member are disclosed.Type: GrantFiled: February 4, 2011Date of Patent: May 6, 2014Assignee: Apollo Endosurgery, Inc.Inventors: Babak Honaryar, Marcos Borrell, Christopher S. Mudd, Joseph S. Raven, Jeff Allen, Sean Snow, Vernon L. Vincent
-
Patent number: 8708979Abstract: The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port and method for attaching an access port to a patient. In addition, a tube guard, tube shroud, tissue guard, porous coupling member and a prefabricated mesh member may be attached to the access port. For example, the prefabricated mesh may be coupled to the access port to facilitate securing the access port to the tissue of the patient.Type: GrantFiled: October 14, 2010Date of Patent: April 29, 2014Assignee: Apollo Endosurgery, Inc.Inventors: Babak Honaryar, Marcos Borrell, Christopher S. Mudd, Joseph S. Raven, Sean Snow, Vern L. Vincent
-
Publication number: 20140051918Abstract: A gastric banding system is provided which generally includes a gastric band and an active agent, for example, a metabolic agent or satiety inducing agent. The band may be structured to contain the agent and permit controlled release of the agent to the patient while the band is positioned around the stomach. Methods for treating obesity are also provided which include positioning a gastric band on the stomach of a patient and administering a satiety inducing agent to the patient while the gastric band is positioned on the stomach. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.Type: ApplicationFiled: October 25, 2013Publication date: February 20, 2014Applicant: Allergan, Inc.Inventors: Joseph S. Raven, Janel A. Birk
-
Publication number: 20130197661Abstract: The present specification discloses porous materials, methods of forming such porous material, biocompatible implantable devices comprising such porous materials, and methods of making such biocompatible implantable devices. The porous material may be used to fix to the interior mucosal lining of a patient's gastrointestinal tract.Type: ApplicationFiled: August 2, 2012Publication date: August 1, 2013Applicant: ALLERGAN, INC.Inventors: Justin J. Schwab, Joseph S. Raven, Futian Liu
-
Publication number: 20120245553Abstract: An implantable intragastric volume occupying device system is provided which generally includes a volume occupying device and an active agent, for example, a metabolic agent or satiety inducing agent. The volume occupying device may be structured to contain the agent and permit controlled release of the agent to the patient while the volume occupying device is positioned within the patient's stomach. Methods for treating obesity are also provided which include positioning a volume occupying device in the stomach of a patient and administering a satiety inducing agent to the patient while the volume occupying device is positioned in the stomach. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.Type: ApplicationFiled: March 25, 2011Publication date: September 27, 2012Applicant: ALLERGAN, INC.Inventors: Joseph S. Raven, Janel A. Birk
-
Publication number: 20120232460Abstract: An intraluminal sleeve system is provided, which generally includes an intraluminal sleeve capable of dispensing an active agent to a patient, for example, a metabolic agent or satiety inducing agent. The intraluminal sleeve may be structured to contain the active agent and permit controlled release of the active agent to the patient while the intraluminal sleeve is positioned within the patient's intestine. Methods for treating obesity are also provided which include positioning an intraluminal sleeve in a patient's intestine, the intraluminal sleeve being capable of dispensing an active agent to the patient. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.Type: ApplicationFiled: March 11, 2011Publication date: September 13, 2012Applicant: ALLERGAN, INC.Inventors: Joseph S. Raven, Janel A. Birk
-
Publication number: 20120095385Abstract: Intragastric fluid transfer devices and related methods for operation thereof are disclosed. The intragastric fluid transfer devices and related methods are intended to assist a patient in maintaining a healthy body weight by stimulating the inner stomach walls and/or the inner duodenum walls. Features of the intragastric fluid transfer device include insertion of the devices transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these intragastric fluid transfer devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer.Type: ApplicationFiled: October 18, 2011Publication date: April 19, 2012Applicant: ALLERGAN, INC.Inventors: Zachary Dominguez, Joseph S. Raven, Mitchell H. Babkes
-
Publication number: 20120089172Abstract: The present application provides implantable intragastric devices for the treatment of obesity. The intragastric devices advantageously act as a volume-occupying device, and is able to survive implantation in a patient's stomach for a year or longer. In addition, the intragastric devices may be configured to stimulate an inner stomach wall and/or temporarily block the pylorus to slow gastric emptying and/or be rotationally variant, thereby encouraging different stimulation points on the inner wall of the stomach and limiting the stomach's ability to adapt over long term implantation. The intragastric devices may reshape the stomach cavity, such as by pushing on opposite sides so as to “planarize” the stomach. For instance, the device may be an inflated disk, or an implantable loop or a springy coil that may be straightened for delivery/extraction yet assume the loop or coil shape upon implant.Type: ApplicationFiled: October 10, 2011Publication date: April 12, 2012Applicant: ALLERGAN, INC.Inventors: Mitchell H. Babkes, Zachary Dominguez, Christopher S. Mudd, Joseph S. Raven
-
Publication number: 20120083650Abstract: The present invention provides for an obesity treatment system for use in conjunction with a gastric band suitable for laparoscopic placement around a stomach of a patient to create a stoma. The obesity treatment system may use real-time objective measurement and clinical data to provide an optimal gastric band adjustment for the patient. The obesity treatment system may include a pressure sensing device coupled to the gastric band, and configured to detect a maximum tolerable pressure, and a pressure changing device coupled to the gastric band, and configured to adjust the gastric band for asserting an optimal pressure against the stomach of the patient, the optimal pressure based on an optimal pressure percentage and the maximum tolerable pressure.Type: ApplicationFiled: September 30, 2010Publication date: April 5, 2012Applicant: ALLERGAN, INC.Inventor: Joseph S. Raven
-
Publication number: 20110251453Abstract: The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port and method for attaching an access port to a patient. In addition, a tube guard, tube shroud, tissue guard, porous coupling member and a prefabricated mesh member may be attached to the access port. For example, the prefabricated mesh may be coupled to the access port to facilitate securing the access port to the tissue of the patient.Type: ApplicationFiled: October 14, 2010Publication date: October 13, 2011Applicant: ALLERGAN, INC.Inventors: Babak Honaryar, Marcos Borrell, Christopher S. Mudd, Joseph S. Raven, Sean Snow, Vernon L. Vincent
-
Publication number: 20110218392Abstract: The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port with a bottom exit port and method for attaching an access port to a patient. In addition, a tube guard, flexible tube exit port, tissue guard, and porous coupling member are disclosed.Type: ApplicationFiled: February 4, 2011Publication date: September 8, 2011Applicant: ALLERGAN, INC.Inventors: Babak HONARYAR, Marcos Borrell, Christopher S. Mudd, Joseph S. Raven, Jeff Allen, Sean Snow, Vernon L. Vincent